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Purpose:We aim to characterize infarct volume evolution within the ﬁrst month post-ischemic stroke and to de-
termine the effect of recanalization status on early infarct volume estimation.
Methods: Ischemic stroke patients recruited for the MONITOR and VISION studies were retrospectively screened
and patients who had infarcts on diffusion-weighted imaging (DWI) at baseline and had at least two follow-up
MR scans (n = 56) were included. Pre-deﬁned target imaging time points, obtained on a 3-T MR scanner,
were 12 hours (h), 24 h, 7 days, and≥30 days post-stroke. Infarct tissue wasmanually traced blinded to the im-
ages at the other time points. Infarct expansion indexwas calculated by dividing infarct volume at each follow-up
time point by the baseline DWI infarct volume. Recanalization was assessed within 24 h post-stroke. Correlation
and statistical comparison analysis were done using the Spearman, Mann–Whitney, and Kruskal–Wallis tests.
Results: Follow-up infarct volumes were positively correlated with the baseline infarct volume (ρ N 0.81;
p b 0.001) where the strongest correlation existed between baseline and 7-day post-stroke infarct volumes
(ρ= 0.92; p b 0.001). The strongest correlation among the follow-up imaging was found between infarct vol-
umes 7-day post-stroke and ≥30-day time points (ρ = 0.93; p b 0.001). Linear regression showed a close-to
unity slope between 7-day and ﬁnal infarct volumes (slope = 1.043; p b 0.001). Infarct expansion was higher
in the non-recanalized group than the recanalized group at the 7-day (p = 0.001) and ≥30-day (p = 0.038)
time points.
Conclusions: Final infarct volume can be approximated as early as 7 days post-stroke. Final infarct volumeapprox-
imation is signiﬁcantly associated with recanalization status.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Final infarct volume is a clinically usefulmeasure associatedwith the
stroke functional outcome (Lev et al., 2001). It is also linked to multiple
other baseline radiological scores such as the Alberta Stroke Program
Early Computed Tomography Score (ASPECTS) (Coutts et al., 2004),
clot burden score (Tan et al., 2009), and clinical parameters,othills Medical Centre, 1403 29
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. This is an open access article undere.g., National Institute of Health Stroke Scale (NIHSS) (Saver et al.,
1999). Final infarct volumedepicts the extent of infarct growth and pro-
vides a gold standard criterion to study the efﬁcacy of treatment/man-
agement strategies (Olivot et al., 2008; Eilaghi et al., 2014). While
infarct progression is widely accepted to be a dynamic process, ﬁnal in-
farct volumehas beenmeasured at different timepoints in these various
studies, such as after 90 days (Warach et al., 2000; Warach et al., 2006;
Davis et al., 2008), 30 days, (Olivot et al., 2008; Hacke et al., 2005; Furlan
et al., 2006) and 5 days (Wheeler et al., 2013; Lemmens et al., 2013).
There is a tendency to use earlier time points in more recent Phase 2
clinical trials and proof-of concept studies to minimize patient drop
out, minimize stroke-related complications, and reduce the overall
study costs. Gaudinski et al. (2008) for example, showed that the infarct
volume stabilized 30 days post-stroke compared to 3 months in 19 pa-
tients with acute stroke.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
Patient baseline characteristics.
Characteristics Value
Mean age years (SD) 68 (12)
Female sex, number (%) 24 (43)
Hypertension, number (%) 30 (54)
Mean glucose level (mmol/l) (SD) 7.2 (2.6)
Diabetes mellitus, number (%) 9 (16)
Right hemisphere (%) 27 (48)
Mean systolic pressure (mm Hg) (SD) 156.2 (28.9)
Mean diastolic pressure (mm Hg) (SD) 82.5 (18.9)
Mean baseline NIHSS (SD) 5 (5)
Thrombolytic treatment, number (%) 12 (21)
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andﬁnal infarct volume in patientswith acute ischemic stroke (Rha, and
Saver, 2007). Early recanalization is believed to improve the chance of
survival in affected ischemic tissues. Therefore, it is reasonable to as-
sume that recanalization status would change the infarct volume evolu-
tion. However, the exact association of infarct volume evolution with
recanalization has not been quantiﬁed, particularly at the sub-acute
stage. For example, it is unclear whether recanalization status affects
the estimation of infarct volume size at the sub-acute stage. Recently,
a linear association was reported between infarct volumes at the sub-
acute (3–6 days) and chronic (N30 days) stages with both time points
showing equivalent predictive value of the clinical outcome in a highly
recanalized (68%) cohort (Tourdias et al., 2011). However, prediction of
the ﬁnal infarct volume at the early time points may be more useful in
patients who do not recanalize. In such patients, prolonged follow-up
is difﬁcult to attain, as these patients are prone to clinical complications.
This study aimed to characterize infarct volume expansion in a pop-
ulation of patients with an intracranial occlusion who are at risk for in-
farct expansion after the baseline scans.We hypothesized that scanning
at 7 days would be a good surrogate of ﬁnal infarct volume.
2. Methods
2.1. Patient selection
This is a retrospective analysis of patients who enrolled in the
MONITOR (Simon et al., 2005) or VISION (Coutts et al., 2008; Coutts
et al., 2011) studies. The institutional research ethics board approved
both studies and patients or their surrogates providedwritten informed
consent. The VISION and MONITOR studies were imaging studies com-
pleted in acute ischemic stroke and TIA patients. A subset of patients
with evidence of a middle cerebral artery (MCA) occlusion had serial
imaging completed as part of these studies. Patients were eligible for
the current analysis if they had baseline imaging including diffusion
weighted (DWI) imaging (b6 h), follow-up ﬂuid attenuated inversion
recovery (FLAIR) imaging (N30 days), and at least one further FLAIR im-
aging at a pre-deﬁned time point between these 2 scans. All patients
had evidence of an MCA occlusion on MRA.
2.2. Image acquisition
Pre-deﬁned target imaging time points included: baseline (b6 h),
12h, 24 h, 7 days, and N30days after stroke onset. Imageswere obtained
using a 3 TMRI (Signa VH/i; GE Healthcare)with high performance gra-
dients (40 mT/m; 184 µs rise time) using a standard quadrature head
coil and established stroke imaging protocols (Lauzon et al., 2006).
Single-shot echo-planar imaging was used for diffusion-weighted im-
ages (b = 0 s mm−2 and isotropic b = 1000 s mm−2; repetition
time = 9000 ms; echo time = min [80–90 ms]; 240 mm ﬁeld-of-
view; 5.0mmslice thicknesswith a 0 or 2mmgap). ADCmapswere de-
rived from the b=0 s mm−2 and b= 1000 s mm−2 images (DeVetten
et al., 2010). FLAIR images were acquired with repetition time =
9002 ms; echo time = 140 ms; inversion time = 2250 ms; 240 mm
ﬁeld-of-view; 3.0mmslice thickness; and 2.0mmgap. MR angiography
(MRA) was performed using 3D time-of-ﬂight imaging using repetition
time= 22ms; echo time= 3.3 ms; ﬂip angle = 15°; acquisition band-
width of ±12.5 kHz; and a 320 × 256 × 44 mm acquired volume.
2.3. Image analysis
Images were assessed blinded to patient identiﬁers and time points
by tracing lesions on DWI and FLAIR images in CEREBRA medical imag-
ing software, (Gobbi et al., 2012) (M.K., A.E.) and edited using MIPAV
(Medical Image Processing, Analysis, and Visualization, BIRSS; NIH, Be-
thesda, Maryland, USA). Acute lesions were identiﬁed on baseline DWI
while follow-up lesions were identiﬁed on FLAIR images. The infarctregions were conﬁrmed by a stroke neurologist (M.A.). Infarct expan-
sion index was calculated by ﬁnding the ratio of the infarct volume on
FLAIR imaging at each time point to the baseline DWI infarct volume.
To assess the effect of initial infarct volume, the cohort was then split
into patients with large (≥10 ml; top 20th percentile by volume) and
small (b10 ml) infarct baseline infarct volumes. Recanalization was
assessed on MRA within 24 h post-stroke using the Thrombolysis In
Myocardial Infarction (TIMI) (Anon, 1985) recanalization score (M.A.).
TIMI scores of 2 and 3 (partial and complete recanalization) were con-
sidered evidence of positive recanalization.2.4. Statistical analysis
Values are reported asmean and standard deviation (SD) unless oth-
erwise noted. Normality was tested using the Kolmogorov–Smirnov
tests. The difference between lesion volumes at different time points
was investigated using the Mann–Whitney and Kruskal–Wallis rank
tests. The relationship between lesion volumes at different time points
was investigated using a Spearman rank correlation test. p b 0.05 was
considered statistically signiﬁcant.
3. Results
Overall 964 patients were screened from both MONITOR (Simon
et al., 2005) and VISION (Coutts et al., 2008; Coutts et al., 2011) studies,
and 59 patients were eligible for inclusion in this sub-study. One patient
with evidence of acute hemorrhage and two patients with signiﬁcant
motion artifact were excluded, leaving a total of 56 patients included
in this analysis. The numbers of scans at each imaging time point were
56 (baseline), 17 (12-hour), 29 (1-day), 56 (7-day), and 56 (N30 day).
Patient demographics are shown in Table 1. Post-onset interval for the
DWI was 2 ± 2 h (range: 0.5–6 h), and for the follow-up FLAIR imaging
at the pre-deﬁned nominal study time points was: 12 h (13 ± 8 h,
range: 4–26 h), 1 day (1.1 ± 0.3 day, range: 0.7–1.9 day), 7 days
(6.5 ± 2.7 days, range: 3–11 days), and N30 days (57 ± 11 days,
range: 22–111 days).
An example of infarct volume evolution at different time points is
shown in Fig. 1. Infarct volume at each time point were: 6.45 ±
8.03 ml (baseline), 9.32 ± 9.33 ml (12-hour), 18.81 ± 21.40 ml (1-
day), 16.86 ± 23.07 ml (7-day) and 9.51 ± 14.84 ml (N30 day). The
measured infarct volumes across all time points for all patients were
not normally distributed (Kolmogorov–Smirnov normality tests,
p ≤ 0.003). Fig. 2 shows the median and quartile ranges for infarct vol-
ume. The differences in the median values of infarct volumes were sig-
niﬁcantly different (Kruskal–Wallis test, p ≤ 0.001). The mean ± SD
values of the infarct expansion index by follow-up time were: 1.27 ±
0.97 (12-hour), 2.59 ± 1.80 (1-day), 2.44 ± 1.88 (7-day) and 1.52 ±
1.36(N30 day). Similar to the infarct volumes, the infarct expansion in-
dices were signiﬁcantly different (Kruskal–Wallis test, p ≤ 0.001). The
distribution of infarct expansion indices including median and quartile
ranges is presented in Fig. 3.
Fig. 1. Infarct volume changes in a 79-year-old male patient presented with left-sided weakness and occlusion of the superior division of the right MCA. This ﬁgure represents
diffusion-weighted imaging (DWI) at 5 hours after onset (A) and consecutive ﬂuid attenuated inversion recovery (FLAIR) imaging sessions obtained 12 hours (B), 28 hours (C), 5 days
(D) and 40 days (E) post stroke.
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tion between infarct volumes measured at multiple time points.
Correlation coefﬁcients (ρ) ranged from 0.80 to 0.93 (p b 0.001
across all 10 (4 + 3 + 2 + 1) pairwise Spearman rank correlation
combinations). The largest correlation coefﬁcient (ρ = 0.93) wasFig. 2. Infarct volume distribution measured at consecutive imaging time points. In this
box plot, the ends of the boxes deﬁne the 25th and 75th percentiles, with a line at theme-
dian and error bars extending to the 10th and 90th percentiles.found between 7-day and ﬁnal time points, whereas the smallest
correlation coefﬁcient (ρ = 0.80) was found between 24-h and
ﬁnal infarct volumes.Fig. 3. Infarct expansion index, calculated as the infarct volume divided by lesion size on
the baseline DWI, declines after the sub-acute phase within the ﬁrst week post-stroke.
Ends of the boxes deﬁne the 25th and 75th percentiles, with a line representing themedi-
an value and error bars extending to the 10th and 90th percentiles.
Fig. 4. Linear regression analysis of 7-day and ﬁnal infarct volumes. The solid line repre-
sents the regression line and dashed lines represent the 95% prediction and conﬁdence in-
tervals. Calculated p values for slope (1.043) and intercept (3.734)were b0.001 and 0.009,
respectively.
Fig. 6. Infarct expansionwas signiﬁcantly different in recanalized (R) and non-recanalized
(NR) groups at both 7-day and ﬁnal (N30-day) time points. Ends of the boxes deﬁne the
25th and 75th percentiles, with a line at the median and error bars extending to the
10th and 90th percentiles.
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and ﬁnal infarct volumes in the smaller baseline infarct volume group
were ρ=0.919 and p b 0.001, and in the larger baseline infarct volume
group were ρ= 0.833 and p= 0.002. A linear regression analysis of 7-
day and ﬁnal infarct volumes showed a slope of 1.04 (p b 0.001) and in-
tercept of 3.734 (p=0.009) with R= 0.89 (Fig. 4). Bland-Altman anal-
ysis found a mean =−0.7 and standard deviation of 0.8 in difference
between infarct expansion indices at 7-day and ﬁnal assessment time
points (Fig. 5).
Patients with successful recanalization (n= 30) had a lower infarct
expansion index than the non-recanalized group (n= 15) at the 7-day
(Mann–Whitney test, p = 0.001) and ﬁnal (Mann–Whitney test, p =
0.038) assessment time points (Fig. 6). Patients in the non-recanalized
group showed a stronger Spearman correlation between 7-day and
ﬁnal infarct volumes (ρ = 0.727; p = 0.009) than those in the
recanalized group (ρ = 0.566, p = 0.002). No signiﬁcant differences
were found in infarct expansion of patients treated (n = 9) and not-
treated (n = 45) with intra-venous tPA at the 7-day (Mann–Whitney
test, p= 0.712) and ﬁnal (Mann–Whitney test, p= 0.623) assessment
time points.Fig. 5. Bland-Altman analysis of infarct expansion at 7-day and ﬁnal assessment time
points.4. Discussion
This study demonstrates the feasibility of approximating ﬁnal infarct
volume based on 1-week post-stroke volumes. While infarct volumes
were signiﬁcantly different at all time-points, the strongest correlation
was found between infarct volume assessments at 7-day and N30 day
time points. Further, patients with negative recanalization status
showed even stronger correlations between 7-day and N30 day ﬁnal in-
farct volumes.
Early estimation of the ﬁnal infarct volume can substantially mini-
mize dropout rates from clinical trials, decrease costs, and reduce the
need for repeat imaging. Our data are consistent with the recent litera-
ture showing some level of overestimation in the infarct volume 7 days
post-stroke, compared to volumes after a month (Figs. 2 and 3)
(Gaudinski et al., 2008). However, a strong correlation between later in-
farct volumes is to be expected. A Bland-Altman analysis of the infarct
expansion at these two time points suggests that approximation of the
ﬁnal volume is feasible 7 days post-onset. This ﬁnding is also consistent
with a previous study (Tourdias et al., 2011), which showed that the
3–6 day assessments of infarct volume provide the same predictive
value of the stroke clinical outcome as chronic volume assessments.
High correlation between the 7-day and N30 day infarct volumes sup-
ports a similar correlation pattern between NIHSS and infarct volume
assessed after sub-acute, and chronic time points (Ebinger et al., 2009).
We found stronger correlations between early (7-day) and ﬁnal
(N30 day) assessments in patients who failed to achieve recanalization.
This observation indicates that in these patients the infarct core tends to
expand into the penumbra in the absence of recanalization. Therefore,
the FLAIR imaging abnormality seen on early assessments without re-
canalization represents an accurate approximation of the ﬁnal infarct
region. In addition, early assessment of the ﬁnal infarct volume in
these patient cohorts is important because these patients are typically
impaired clinically and aremore likely to be excluded from clinical trials
due to loss of long-term follow-up. This exclusion can lead to biased in-
terpretation of the study results since the focus would be on patients
who recanalized and experienced a less severe stroke. For example, it
has been shown that replacing the 90-day infarct volume assessment
with the one week assessment resulted in ﬁve times lower patient
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assessment after the ﬁrst week appears to be sufﬁcient to demonstrate
treatment efﬁcacy (Ebinger et al., 2009) and supports the desirability for
earlier imaging endpoint particularly in Phase 2 clinical trials and proof-
of-concept studies (MR Stroke Collaborative Group et al., 2006). Early
follow-up imaging has been already adopted in a multicenter prospec-
tive cohort study to assess response to endovascular reperfusion
(Lansberg et al., 2012).
Early estimation of the ﬁnal infarct volumemay also have important
implications for rehabilitation planning. The correlation between clini-
cal parameters and imaging estimation of the ﬁnal infarct core can be
used to guide the selection of candidateswhowill likely beneﬁt from re-
habilitation. The signiﬁcant association between limited baseline infarct
volume and improved functional recovery after stroke is established
(Heiss et al., 2000). Within the ﬁrst few weeks post-onset, the presence
of pre-infarct edema can result in functional impairment and blurs the
estimation of the ﬁnal infarct core (Rosenberg, 1999). Therefore,
unmasking areas of edema through early approximation of the ﬁnal in-
farct volume may help predict functional recovery and thus intensify
the rehabilitation of such patients (Hu et al., 2010) for improved func-
tional outcome.
This study is subject to several limitations. The data set useddoes not
include imaging for all patients at all time-points. Fifty-six patients en-
tered the study with baseline DWI within 6 h of onset. The smallest
groupwas the early follow-up assessment after 12h (n=17).However,
the majority of patients had imaging at all other time points. In our
study, the average infarct volume and the median baseline NIHSS are
lower than the typical ischemic stroke cohort (Eilaghi et al., 2014). Pa-
tients with smaller stroke volumes were more likely to have imaging
atmultiple timepoints and particularly after 30days post-stroke. There-
fore, results may not necessarily apply to patients with larger or proxi-
mal infarcts. This perhaps explains why only the top 20th percentile of
the cohort had baseline infarct volume N10 ml. Of note, the presented
56 patients were screened from 964 patients that participated in two
single-center clinical trials (Simon et al., 2005; Coutts et al., 2008;
Coutts et al., 2011). Despite the reduced sample size, we were able to
identify a signiﬁcantly higher correlation between 7-day and infarct vol-
umes in those with negative recanalization status. Recanalization status
was obtained during the ﬁrst 24 h, but only provides a single timemea-
sure of vessel state. In this study it was not possible to accurately deter-
mine time of recanalization. Finally, our protocol did not obtain
perfusionmaps at follow-up imaging; reperfusion (occurring spontane-
ously or achieved due to intervention) is known to impact on the dy-
namic of infarct evolution post-stroke (Eilaghi et al., 2013).
In summary,ﬁnal infarct volume approximation is signiﬁcantly asso-
ciatedwith recanalization status of the patient. Final infarct volumes can
be estimated as early as 7 days post-stroke potentially increasing inclu-
sion rate for clinical trials, and reducing the need for repeated imaging,
and decreasing healthcare clinical costs.
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